He X, Sun J, Liu C, Yu X, Li H, Zhang W
As a dual-acting GLP-1 and GIP agonist, this once-weekly injection has helped participants shed up to 20.9% of their body mass in trials, offering enhanced results for those needing substantial weight loss
The medication slows gastric emptying, which means alcohol hits your bloodstream faster and hangs around longer
The 4 mg maintenance dose produced 17.1% average weight loss across the full trial population, but lighter individuals within that group often experienced responses closer to 20% or higher
All-in-one theranostic platform based on hollow microcapsules for intragastric-targeting antiulcer drug delivery, CT imaging, and synergistically healing gastric ulcer